GlaxoSmithKline (GSK)
NYSE:GSK

GlaxoSmithKline Stock Forecast & Price Target

4,098 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Sell
2Ratings
0 Buy
1 Hold
1 Sell
Based on 2 analysts giving stock ratings to
GlaxoSmithKline
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GSK Stock Price Prediction

Average Price Target

$34.00
▲(0.03% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. The average price target is $34.00 with a high forecast of $34.00 and a low forecast of $34.00. The average price target represents a 0.03% change from the last price of $33.99.
Highest Price Target$34.00Average Price Target$34.00Lowest Price Target$34.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
DZ BANK AG
Hold
Downgraded
DZ Bank downgrades GlaxoSmithKline (GSK) to HoldDZ Bank analyst Elmar Kraus downgraded GlaxoSmithKline (NYSE: GSK) from Buy to Hold.
AlphaValue Analyst forecast on GSK
Rishabh Kochar
Not Ranked
AlphaValue
Sell
Downgraded
GSK plc downgraded to Reduce from Add at AlphaValue/BaaderGSK plc downgraded to Reduce from Add at AlphaValue/Baader
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GSK Financial Forecast

GSK Earnings Forecast
Next quarter’s earnings estimate for GSK is $0.57 with a range of $0.49 to $0.67. The previous quarter’s EPS was $1.07. GSK beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year GSK has Outperformed its overall industry.
Next quarter’s earnings estimate for GSK is $0.57 with a range of $0.49 to $0.67. The previous quarter’s EPS was $1.07. GSK beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year GSK has Outperformed its overall industry.
GSK Sales Forecast
Next quarter’s sales forecast for GSK is $8.49B with a range of $8.03B to $9.52B. The previous quarter’s sales results were $9.20B. GSK beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 42.92% of the time in the same period. In the last calendar year GSK has Outperformed its overall industry.
Next quarter’s sales forecast for GSK is $8.49B with a range of $8.03B to $9.52B. The previous quarter’s sales results were $9.20B. GSK beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 42.92% of the time in the same period. In the last calendar year GSK has Outperformed its overall industry.
GSK Analyst Recommendation Trends
In the current month, GSK has received 0 Buy ratings 0 Hold ratings, and 1 Sell ratings. The GSK average analyst price target in the past 3 months is $34.00
In the current month, GSK has received 0 Buy ratings 0 Hold ratings, and 1 Sell ratings. The GSK average analyst price target in the past 3 months is $34.00

GSK Stock Forecast FAQ

What is GSK’s average 12-month price target, according to analysts?
Based on analyst ratings, GlaxoSmithKline’s 12-month average price target is $34.00.
    What is GSK’s upside potential, based on the analysts’ average price target?
    GlaxoSmithKline has 0.03% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GSK a Buy, Sell or Hold?
          GlaxoSmithKline has a conensus rating of Moderate Sell which is based on 0 buy ratings, 1 hold ratings and 1 sell ratings.
            What is GlaxoSmithKline’s price target?
            The average price target for GlaxoSmithKline is $34.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $34.00 ,the lowest forecast is $34.00. The average price target represents 0.03% Increase from the current price of $33.99.
              What do analysts say about GlaxoSmithKline?
              GlaxoSmithKline’s analyst rating consensus is a ‘Moderate Sell. This is based on the ratings of 2 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis